Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | BETA Beta Drugs Limited Pharma · Small | JAGSNPHARM Jagsonpal Pharmaceuticals Limited Pharma · Small | ALEMBICLTD Alembic Limited Pharma · Small | BAJAJHCARE Bajaj Healthcare Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 47 | 57 | 59 | 29 |
| Verdict | FAIR VALUE | FAIR VALUE | FAIR VALUE | OVERVALUED |
| Style | Financial Turnaround | Financial Turnaround | Deep Value | OVERVALUED |
| Piotroski | 8/9 | 8/9 | 8/9 | 7/9 |
| Valuation | 4/30 | 7/30 | 22/30 | 5/30 |
| Growth | 16/25 | 16/25 | 9/25 | 2/25 |
| Quality | 10/20 | 12/20 | 2/20 | 0/20 |
| Balance Sheet | 8/15 | 12/15 | 14/15 | 9/15 |
| Cash Flow | 4/10 | 5/10 | 7/10 | 7/10 |
| Price | ₹1,522.9 | ₹201.75 | ₹87.34 | ₹292.1 |
| P/E | 37.20 | 29.30 | 7.00 | 21.10 |
| P/B | 6.32 | 4.83 | 0.91 | 1.87 |
| ROE | 18.80% | 17.30% | 13.30% | 9.40% |
| ROCE | 19.20% | 22.70% | 6.28% | 11.50% |
| Debt / Equity | 0.60 | 0.03 | 0.00 | 0.47 |
| FCF Yield | — | 0.84% | 2.97% | 1.01% |
| Dividend Y | — | 1.26% | 2.77% | 0.34% |
| Altman Z | 5.81 | 8.98 | 7.84 | 3.55 |
| Promoter % | 64.63% | 67.89% | 70.88% | 58.29% |
| Mkt Cap (₹Cr) | 1544.00 | 1308.00 | 2222.00 | 992.00 |
| Graham # | ₹471.05 | ₹77.2 | ₹162.71 | ₹128.99 |
| Fair PE | 42.0 | 42.0 | 7.3 | 3.8 |
| MoS % | +11.4% | +25.3% | +2.9% | -1555.4% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startBETA91
JAGSNPHARM34
ALEMBICLTD66
BAJAJHCARE74